Lithium (Low-Dose) and Lithium (Low-Dose) for Mood (supplement dose)
Each entry’s own grades, side by side. A grade says how strong the evidence is for one outcome — it does not rank one entry over the other.
Compound or practice
Lithium (Low-Dose)
A trace element sold at microdoses for mood — intriguing epidemiology, almost no supplement-dose trial data.
Grade D1 graded outcomerevised Jul 10, 2026
A structured monograph in Prometheus's bundled library. Its grades are the monograph's own reading of the evidence, not a peer-reviewed review.
Evidence brief
Lithium (Low-Dose) for Mood (supplement dose)
Evidence grade D — Minimal trial data
Grade D1 graded outcomerevised Jul 10, 2026
Assembled by the app from other entries in this library. It adds no evidence of its own — follow the links to the entries it draws on.
Graded in both
Outcomes are matched by name. Two entries can describe the same outcome in different words, so one listed further down may still be graded in the other.
| Outcome | Lithium (Low-Dose) | Lithium (Low-Dose) for Mood (supplement dose) |
|---|---|---|
| Mood (supplement dose) | Evidence grade DUnclear effectlowMinimal trial data | Evidence grade DUnclear effectlowMinimal trial data |
Graded only in Lithium (Low-Dose)
None — every outcome it grades is graded in both.
Graded only in Lithium (Low-Dose) for Mood (supplement dose)
None — every outcome it grades is graded in both.
What each entry says about the other
- Lithium (Low-Dose) for Mood (supplement dose)’s entry · Goes with: Read the full Lithium (Low-Dose) monograph
Both columns are read from the entries as they stand in this library. A comparison is not advice to take either one, and it is no substitute for a clinician who knows the person.